Feedback / Questions
GEC-255 - GenEros
https://www.prnewswire.com/news-releases/generos-to-present-promising-results-of-gec255-phase-i-clinical-trial-for-advanced-nsclc-patients-with-kras-g12c-mutation-301840215.html
Jun 1, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next